Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Association between leukotriene-modifying agents and suicide: what is the evidence?

Schumock GT, Lee TA, Joo MJ, Valuck RJ, Stayner LT, Gibbons RD.

Drug Saf. 2011 Jul 1;34(7):533-44. doi: 10.2165/11587260-000000000-00000. Review.

PMID:
21663330
2.

A randomized, comparative, multicentric clinical trial to assess the efficacy and safety of zileuton extended-release tablets with montelukast sodium tablets in patients suffering from chronic persistent asthma.

Kubavat AH, Khippal N, Tak S, Rijhwani P, Bhargava S, Patel T, Shah N, Kshatriya RR, Mittal R.

Am J Ther. 2013 Mar-Apr;20(2):154-62. doi: 10.1097/MJT.0b013e318254259b.

PMID:
22926233
3.

Risk of suicide attempt in asthmatic children and young adults prescribed leukotriene-modifying agents: a nested case-control study.

Schumock GT, Stayner LT, Valuck RJ, Joo MJ, Gibbons RD, Lee TA.

J Allergy Clin Immunol. 2012 Aug;130(2):368-75. doi: 10.1016/j.jaci.2012.04.035. Epub 2012 Jun 12.

PMID:
22698520
4.

Leukotriene-receptor antagonists.

Lipworth BJ.

Lancet. 1999 Jan 2;353(9146):57-62. Review.

PMID:
10023966
5.

Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?

Wechsler ME, Pauwels R, Drazen JM.

Drug Saf. 1999 Oct;21(4):241-51.

PMID:
10514017
6.

Reports of suicidality in clinical trials of montelukast.

Philip G, Hustad C, Noonan G, Malice MP, Ezekowitz A, Reiss TF, Knorr B.

J Allergy Clin Immunol. 2009 Oct;124(4):691-6.e6. doi: 10.1016/j.jaci.2009.08.010.

PMID:
19815114
7.

Antileukotrienes in asthma: present situation.

García-Marcos L, Schuster A.

Expert Opin Pharmacother. 2001 Mar;2(3):441-66. Review.

PMID:
11336598
8.

[The role of leukotrienes in inflammation and leukotriene inhibitors].

Kupczyk M, Kuna P.

Pol Merkur Lekarski. 1999 Sep;7(39):85-93. Review. Polish.

PMID:
10598480
9.

[Leukotriene antagonists--do they have a value?].

Stey C.

Praxis (Bern 1994). 2000 Mar 30;89(14):586-90. Review. German.

PMID:
10815466
10.

Safety of antileukotriene agents in asthma management.

Spector SL; Antileukotriene Working Group.

Ann Allergy Asthma Immunol. 2001 Jun;86(6 Suppl 1):18-23.

PMID:
11426912
11.

Leukotriene modifiers: new drugs, old and new reactions.

Rosenwasser LJ.

J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):374-5. No abstract available.

PMID:
10069868
12.

Leukotrienes: their role in the treatment of asthma and seasonal allergic rhinitis.

Banasiak NC, Meadows-Oliver M.

Pediatr Nurs. 2005 Jan-Feb;31(1):35-8. Review. No abstract available.

PMID:
15794321
13.

Recurrent panniculitis in a man with asthma receiving treatment with leukotriene-modifying agents.

Dellaripa PF, Wechsler ME, Roth ME, Drazen J.

Mayo Clin Proc. 2000 Jun;75(6):643-5.

PMID:
10852428
14.

Leukotriene receptor antagonists in the treatment of allergic rhinitis.

Maynard ML, Ernst ME.

Ann Pharmacother. 2001 Oct;35(10):1274-7. Review.

PMID:
11675859
15.

Psychiatric Disorders and Montelukast in Children: A Disproportionality Analysis of the VigiBase(®).

Aldea Perona A, García-Sáiz M, Sanz Álvarez E.

Drug Saf. 2016 Jan;39(1):69-78. doi: 10.1007/s40264-015-0360-2.

PMID:
26620206
16.

Montelukast in the treatment of allergic rhinitis: an evidence-based review.

Nayak A, Langdon RB.

Drugs. 2007;67(6):887-901. Review.

PMID:
17428106
17.

Where do leukotriene modifiers fit in asthma management?

Janson S, Lazarus SC.

Nurse Pract. 2002 Apr;27(4):19, 23-4, 26-9; quiz 30-1. Review.

PMID:
11984416
18.

Asthma Treatments and Mental Health Visits After a Food and Drug Administration Label Change for Leukotriene Inhibitors.

Lu CY, Zhang F, Lakoma MD, Butler MG, Fung V, Larkin EK, Kharbanda EO, Vollmer WM, Lieu T, Soumerai SB, Chen Wu A.

Clin Ther. 2015 Jun 1;37(6):1280-91. doi: 10.1016/j.clinthera.2015.03.027. Epub 2015 Apr 25.

19.

[Churg-Strauss syndrome after treatment with Singulair (montelukast)].

Hammer HB, Aukrust P, Frøland SS.

Tidsskr Nor Laegeforen. 2002 Feb 20;122(5):484-6. Norwegian.

PMID:
11961976
20.

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.

Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL.

Pediatrics. 2001 Sep;108(3):E48.

PMID:
11533366

Supplemental Content

Support Center